sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

BACKGROUND: The widespread use of the integrase strand transfer inhibitor (INSTI) dolutegravir (DTG) in first- and second-line antiretroviral therapy (ART) may facilitate emerging resistance. We combined data from HIV cohorts to examine patterns of drug resistance mutations (DRMs) and identify risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosli, Tom, Hossmann, Stefanie, Ingle, Suzanne M., Okhai, Hajra, Kusejko, Katharina, Mouton, Johannes, Bellecave, Pantxika, van Sighem, Ard, Stecher, Melanie, d’Arminio Monforte, Antonella, Gill, M. John, Sabin, Caroline A., Maartens, Gary, Günthard, Huldrych F., Sterne, Jonathan A. C., Lessells, Richard, Egger, Matthias, Kouyos, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104228/
https://www.ncbi.nlm.nih.gov/pubmed/37066200
http://dx.doi.org/10.1101/2023.04.05.23288183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104228/
https://www.ncbi.nlm.nih.gov/pubmed/37066200
http://dx.doi.org/10.1101/2023.04.05.23288183

Ejemplares similares